Glatiramer Prefilled Syringe [Glatopa]
Semantic Scholar uses AI to extract papers important to this topic.
Abstract Objective: To compare relapse rates and healthcare costs in MS patients treated with Glatopa 20 mg (generic glatiramer… Expand The multiple sclerosis (MS) treatment landscape in the United States has changed dramatically over the past decade. While many… Expand Background: In April 2015, the US Food and Drug Administration approved the first generic glatiramer acetate, Glatopa® (M356), as… Expand Glatopa™ is a generic glatiramer acetate recently approved for the treatment of patients with relapsing forms of multiple… Expand Glatiramer acetate (GA) has been available under the brand name Copaxone® for nearly two decades. Recently, the US Food and Drug… Expand